49) Inspired from nature’s design – From new antimicrobial strategies, bioresponsive prodrugs compounds and extracellular-targeted drug conjugates, 19.11.2024, AstraZeneca, Department of Respiratory and Immunology Diseases, Göteborg, Sweden.

 

48) Inspired from nature’s design – From bioresponsive tool compounds and cancer selective migrastatics, Division of Chemical Biology, Chalmers University, 02.10.2024, Gothenburg, Sweden.

 

47) Inspired from nature’s design – From bioresponsive tool compounds and cancer selective migrastatics, virtual talk at Highlights of Organic Chemistry in Sweden Webinar by EuChemS, 29.09.2024, Gothenburg, Sweden

 

46) Opening a therapeutic window - Novel antimycobacterial Griselimycin derivatives with reduced off-target activity, CARe Meeting, 10.06.2024, Gothenburg, Sweden

 

45) Semi-synthetic modification of cytochalasans – From fluorescent cytochalasans, first steps towards bio-responsive migrastatics and probes for target-fishing, CytoLabs Symposium 2024, 24.05.2024, Braunschweig, Germany

 

44) Mimicking nature´s design – pseudoglucosinolates as prodrugs for bioresponsive isothiocyanate release, 4th Swedish Medicinal Chemistry Symposium, 17.-18.04.2024, Stockholm, Sweden.

 

43) Mimicking nature´s design – From antimicrobial siderophore-drug conjugates, novel griselimycins and artificial glucosinolates, CAAPS-Kolloquium, Centre for Advanced Analytics and Predictive Sciences, 27.02.2024, Universität Augsburg, Germany.

 

42) Inspired by nature´s design – Natural product derived drugs, bioresponsive tool compounds and extracellular-targeted drug and reporter conjugates, WCMTM PI talks, University of Gothenburg, 22.02.2024, Göteborg, Germany

 

41) Studies towards the total synthesis of Chaetoglobosin B and semisyntheic derivatization of cytochalasans, CytoLabs Retreat, Leibnitz Universität Hannover, 08.02.2024, Hannover, Germany

 

40) Learning from nature's design – From antimicrobial siderophore-drug conjugates, novel griselimycin derivatives and artificial glucosinolates, AstraZeneca, 13.12.2023, Göteborg, Sweden.

 

39) Mimicking nature´s design – pseudoglucosinolates as prodrugs for bioresponsive isothiocyanate release, 10th anniversary of CBIO, Helmholtz Centre for Infection Research (HZI), 08.12.2023, Braunschweig, Germany.

 

38) Learning from nature's design - The concept of pseudo-glucosinolates and its application in target identification, peptide labelling and prodrug design, Ulla and Stig Holmquist Symposium, 10.10.2023, Uppsala University, Sweden.

 

37) Artificial glucosinolates - Mimicking nature's design, 15.09.2023, Braunschweigische Wissenschaftliche Gesellschaft (BWG), Klassensitzung der Klasse für Mathematik und Naturwissenschaften, Virtual talk.

 

36) Design of Cytochalasan-based tool compounds, 13.09.2023, CytoLabs Retreat 2023, Warburg, Germany

 

35) From antimicrobial siderophore-drug conjugates and artificial glucosinolates, 23.08.2023, 31th GP2A Medicinal Chemistry Conference 2023, Marseille, France

 

34) Inspired by nature´s design – Exploiting the chemistry of artificial glucosinolates (GSLs), 07.06.2023, OC Colloquium, Institute or Organic Chemistry, TU Braunschweig, Germany.

 

33) Inspired by nature´s design – Exploiting the chemistry of artificial glucosinolates (GSLs), 06.06.2023, GDCh Colloquium, TU Darmstadt and Merck KGaA, Darmstadt, Germany.

 

32) Inspired by nature´s design – Exploiting the chemistry of artificial glucosinolates (GSLs), 02.06.2023, virtual talk at National Seminar Series in Organic Chemistry, Organic Division of Svenska Kemisamfundet

 

31) Inspired by nature´s design – From biomimetic enterobactin-drug conjugates and artificial glucosinolates (GSLs), 15.09.2022, Medicinal and Organic Chemistry Symposium 2022, Gothenburg, Sweden.

 

30) Inspired by nature´s design: Biomimetic enterobactin analogues for antimicrobial drug conjugates, 05.09.2022, Vectorization and Innovation against Pathogen Resistance (VIPR), Summerschool ITI InnoVec, Strasbourg, France.

 

29) Inspired by nature´s design – Exploiting the chemistry of artificial glucosinolates (GSLs), 03.09.2022, 8th EuChemS Young Investigator Workshop 2021/2022 (YIW8), Lisbon, Portugal.

 

28) Inspired by nature´s design – Biomimetic enterobactin analogues for antimicrobial drug conjugates, 29.08.2022, 8th EuChemS 2022 (ECC8), Lisbon, Portugal.

 

27) Natural product derived drugs, tailormade drug-conjugates and designed bioresponsive probes for treatment and diagnostic of diseases, 22.08.2022, Department of Psychiatry and Neurochemistry, Sahlgrenska University Hospital, Gothenburg, Sweden

 

26) Inspired by nature´s design – Exploiting the chemistry of artificial glucosinolates (GSLs), 11.05.2022, MedChem Seminar, Department of Chemistry and Molecular Biology, University of Gothenburg, Sweden

 

25) Inspired by nature´s design – Exploiting the chemistry of artificial glucosinolates (GSLs), 25.02.2022, virtual talk at the Department of Chemistry and Molecular Biology, University of Gothenburg, Sweden.

 

24) Inspired by nature´s design: From antimicrobial siderophore-drug conjugates, artificial glucosinolates and turn-on fluorophores, 06.12.2021, virtual talk at the Organic Chemistry Colloquium, Technische Universität Dresden.

 

23) Nature inspired design of drugs, smart fluorescence dyes and bioresponsive tool compounds, 17.11.2021, virtual talk at the TUBS grad school. 

 

22) Inspired by nature´s design: Biomimetic enterobactin analogues for antimicrobial drug conjugates, 06.09.2021, virtual talk at the 4th European Conference of Natural Products (ECNP 2021).

 

21) Inspired by nature´s design: From Biomimetic enterobactin analogues  and fluorescent imaging tools, 10.06.2021, Colloquium of Organic Chemistry and Biochemistry, Department of Chemistry, TU München.

 

20) Inspired by nature´s design: Biomimetic enterobactin analogues for antimicrobial drug conjugates and fluorescent imaging tools, 19.03.2021, Biosolve IT webinar.

 

19) Artificial enterobactin analogues as extracellular-targeted carrier molecules for antimicrobial drug conjugates, 16.03.2021, Chemiedozententagung 2021, virtual conference.

 

18) Development of antimicrobial siderophore-drug conjugates – From artificial siderophores, novel payloads, bioresponsive linkers and smart fluorescent dyes, 03.12.2020, Georg-August Universität Göttingen, Institut für Organische und Biomolekulare Chemie/MBExC Multiscale Bioimaging- Cluster of Excellence.

 

17) Neue Wege gegen Gram-negative Pathogene - Antimikrobielle Wirkstoff-Konjugate auf Basis von artifiziellen Enterobactin-Analoga, 13.11.2020, Braunschweigische Wissenschaftliche Gesellschaft (BWG) Klassensitzung der Klasse für Mathematik und Naturwissenschaften, Braunschweig. 

 

16) Design, synthesis and evaluation of extracellular-targeted drug conjugates and smart fluorescent dyes, 18.06.2020, Organic Chemistry Colloquium, Fakultät für Mathematik und Naturwissenschaften, Institut für Chemie, Bergische Universität Wuppertal (BUW), Wuppertal. (Cancelled due to COVID-19 pandemic)

 

15) Design, synthesis and evaluation of extracellular-targeted drug conjugates and smart fluorescent dyes, 06.05.2020, Organic Chemistry Colloquium, Institut für Chemie, Technische Universität München (TUM), Garching. (Cancelled due to COVID-19 pandemic)

 

14) Artificial enterobactin analogues as extracellular-targeted carrier molecules for antimicrobial drug conjugates, 01.04.2020, German-Japanese Natural Product Chemistry Symposium, Shizuoka, Japan. (Cancelled due to COVID-19 pandemic)

 

13) Artificial enterobactin analogues as extracellular-targeted carrier molecules for antimicrobial drug conjugates, 31.03.2020, Chemiedozententagung 2020, TU Dresden, Dresden. (Cancelled due to COVID-19 pandemic)

 

12) Inspired by nature´s design: Artificial enterobactin analogues for antimicrobial drug conjugates and smart fluorescence dyes, Symposium of the DFG Collaborative Research Centre TR-SFB 261, 10.12.2019, Kekulé-Institute of Organic Chemistry and Biochemistry, Rheinischen Friedrich-Wilhelms-Universität Bonn, Bonn.

 

11) Design, synthesis and evaluation of extracellular-targeted drug conjugates and smart fluorescent dyes, 28. Nachwuchswissenschaftler-Symposium Bioorganische Chemie, 24.09.2019, Universität Duisburg-Essen, Essen.

 

10) Design, synthesis and evaluation of extracellular-targeted drug conjugates and smart fluorescent dyes, 19.09.2019, BMWZ Symposium, BMWZ/Leibniz Universität Hannover, Hannover.

 

9) Artificial enterobactin analogues and TML-based linkers as building blocks for antimicrobial siderophor-drug conjugates and development of glucosinolate-based, bioresponsive reporter molecules, 26.04.2019, Helmholtz Institut für Pharmazeutische Forschung Saarland (HIPS), Saarbrücken.

 

8) Development of natural product-based antibacterials targeting the sliding clamp DnaN (NaPAnti) - Development of novel bifunctional GM hybrid antimicrobials and conjugates, Kick-Off Meeting NaPAnti-BMBF-Project, 25.04.2019, Helmholtz Institut für Pharmazeutische Forschung Saarland (HIPS), Saarbrücken.

 

7) Development of a universal synthetic de novo access to all cytochalasan sub-classes and novel cytochalasan derivatives - A comprehensive, combinatorical approach for the exploration of the target selectivity of the cytochalasans, Initiationsmeeting DFG Researcher group Application, 12.03.2019, BMWZ, Leibnitz Universität Hannover.

 

6) Artificial enterobactin analogues and TML-based linkers as building blocks for antimicrobial siderophor-drug conjugates and development of glucosinolate-based, bioresponsive reporter molecules, 31. Irseer Naturstoff-tagung, 20.02.2019, Kloster Irsee.

 

5) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, Advances in Chemical Biology 2018, Dechema, 30.01.2018, Frankfurt am Main.

 

4) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, Bundesfachtagung (BuFaTa) Chemie, 03.11.2017. Braunschweig.

 

3) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, 21. Mitgliederversammlung des Fördervereins der Freunde des Instituts für Organische Chemie an der Technischen Universität Braunschweig e.V., 21.10.2017, Braunschweig.

 

2) Einmal Texas und zurück – Ein Weg in die Akademie, Netzwerker-Tagung der Alexander-von-Humboldt Stiftung, 20.10.2017, Bielefeld.

 

1) Novel extracellular-targeted Drug-Conjugates based on Ratjadone A, 26. Nachwuchswissenschaftler-Symposium Bioorganische Chemie, 20.09.2017, TU Berlin.